Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wildlife Laboratories is a specialized pharmaceutical company dedicated to the development and supply of immobilization and anesthesia drugs for wildlife and exotic animals. The company is widely recognized for its proprietary formulations, such as BAM (Butorphanol + Azaperone + Medetomidine), which provide safe and reversible sedation for a variety of species. Their product portfolio includes a range of analgesics, sedatives, and reversal agents used by veterinarians, researchers, and wildlife management professionals globally. Following its acquisition by NexGen Pharmaceuticals, the company continues to serve the niche market of zoological and wildlife medicine with high-quality, species-specific chemical immobilization solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wildlife Laboratories.